Stockscreener 앱 받기
10.20
2.87%
-0.245
전일 마감가:
$10.44
열려 있는:
$10.41
하루 거래량:
61,696
Relative Volume:
0.08
시가총액:
$554.09M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-8.73%
1개월 성능:
+12.54%
6개월 성능:
-16.41%
1년 성능:
+0.00%
1일 변동 폭
$9.83
$10.41
1주일 범위
$9.83
$11.51
52주 변동 폭
$7.80
$28.09
Bicara Therapeutics Inc Stock (BCAX) Company Profile
명칭
Bicara Therapeutics Inc
전화
617-785-8308
주소
245 MAIN STREET, CAMBRIDGE
BCAX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BCAX
Bicara Therapeutics Inc
|
10.16 | 619.53M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.92 | 96.11B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 60.40B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.06 | 54.91B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
672.75 | 41.30B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
296.29 | 33.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Bicara Therapeutics Inc Stock (BCAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-23 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2025-04-17 | 개시 | Wells Fargo | Underweight |
| 2025-02-06 | 개시 | Wedbush | Outperform |
| 2024-12-06 | 개시 | H.C. Wainwright | Buy |
| 2024-11-05 | 개시 | Rodman & Renshaw | Buy |
| 2024-10-08 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-10-08 | 개시 | Morgan Stanley | Overweight |
| 2024-10-08 | 개시 | Stifel | Buy |
| 2024-10-08 | 개시 | TD Cowen | Buy |
모두보기
Bicara Therapeutics Inc 주식(BCAX)의 최신 뉴스
Price Channel Expanding on Bicara Therapeutics Inc.’s ChartEarly Entry Picks Before News Breakout Reviewed - beatles.ru
Is Bicara Therapeutics Inc. stock overvalued or undervaluedStrong return on investment - Jammu Links News
How volatile is Bicara Therapeutics Inc. stock compared to the marketMaximize returns with disciplined trading - Jammu Links News
What analysts say about Bicara Therapeutics Inc. stockUnprecedented profits - Jammu Links News
What is Bicara Therapeutics Inc. company’s growth strategyMaximize gains with expert analysis - Jammu Links News
What are the latest earnings results for Bicara Therapeutics Inc.Exceptional stock performance - Jammu Links News
How does Bicara Therapeutics Inc. compare to its industry peersPhenomenal capital appreciation - Jammu Links News
Does Bicara Therapeutics Inc. stock perform well during market downturnsTake advantage of unprecedented market momentum - Jammu Links News
Is Bicara Therapeutics Inc. the Top Chart Pick This WeekEntry Points For Growing Stocks Identified by Models - beatles.ru
Is it the right time to buy Bicara Therapeutics Inc. stockBreakout Stocks Tips That Work - jammulinksnews.com
What institutional investors are buying Bicara Therapeutics Inc. stockLow Risk Recommendation That Work - Jammu Links News
Will Bicara Therapeutics Inc. Benefit From Broader Market BounceROI Boosting Trade Opportunity Calendar Published - metal.it
Bicara Therapeutics Inc. Inches Above Key Support — Safe to HoldWealth Building Stock Market Ideas Based on Momentum - metal.it
RSI Crosses Above 30 for Bicara Therapeutics Inc. — Reversal in SightGrowth Based Investment Plan Guidance Highlighted - metal.it
Bicara Therapeutics Inc. Shows Risk Reward Favoring UpsideEntry Alert Based on Volume Spikes Detected - metal.it
Will Bicara Therapeutics Inc. Recover After Recent DeclineConservative Entry for High Return Setup Backed - beatles.ru
When is Bicara Therapeutics Inc. stock expected to show significant growthSmart Portfolio Strategy For Beginners - jammulinksnews.com
How Bicara Therapeutics Inc. stock performs during market volatilityValue Investing Picks With Stability Outlined - metal.it
Bicara Therapeutics Inc. Stock Approaches Key Moving AverageROI Driven Equity Selection With Safety Emphasized - metal.it
Real time breakdown of Bicara Therapeutics Inc. stock performanceDaily Stock Forecast Powered by AI Tools - Newser
Why is Bicara Therapeutics Inc. stock attracting strong analyst attentionGain access to exclusive stock analysis - jammulinksnews.com
Bicara Therapeutics Inc. Stock Performance After Earnings: Historical InsightsDefensive Stock Picks with Upside - Newser
Is Bicara Therapeutics Inc. a good long term investmentExceptional stock performance - PrintWeekIndia
What drives Bicara Therapeutics Inc. stock priceSky-high return potential - PrintWeekIndia
What analysts say about Bicara Therapeutics Inc. stock outlookSuperior investment outcomes - Jammu Links News
Is Bicara Therapeutics Inc. stock a good hedge against inflationExtraordinary profit generation - jammulinksnews.com
Will Bicara Therapeutics Inc. stock benefit from interest rate changesDynamic investment growth - Jammu Links News
Bicara Therapeutics Inc. Stock Analysis and ForecastFree Investment Community - jammulinksnews.com
Bicara Therapeutics Inc (BCAX) 재무 분석
Bicara Therapeutics Inc (BCAX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Bicara Therapeutics Inc 주식 (BCAX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Meisner Lara | Chief Legal Officer |
Jun 16 '25 |
Sale |
10.43 |
15,829 |
165,096 |
0 |
0.43%
1.83%
자본화:
|
볼륨(24시간):